Kiniksa Pharmaceuticals International, plc (KNSA)

NASDAQ: KNSA · Real-Time Price · USD

59.20

+2.31 (4.06%)

At close: Jun 26, 2026, 4:00 PM EDT

59.97

+0.77 (1.30%)

Pre-market: Jun 29, 2026, 8:08 AM EDT

KNSA Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	4,555	3,147	1,434	1,236	1,044	813
Market Cap Growth	106.55%	119.41%	16.06%	18.37%	28.45%	-32.56%
Enterprise Value	4,096	2,743	1,201	1,042	859.38	636.69
Last Close Price	59.20	41.25	19.78	17.54	14.98	11.77
PE Ratio	65.22	55.00	-	87.70	5.76	-
Forward PE	46.71	27.32	42.93	-	-	-
PS Ratio	6.04	4.64	3.39	4.57	4.74	21.09
PB Ratio	7.20	5.54	3.27	2.82	2.64	4.39
P/TBV Ratio	8.07	5.90	3.35	2.99	2.79	4.87
P/FCF Ratio	27.73	23.07	56.44	93.83	183.11	-
P/OCF Ratio	27.46	22.81	55.84	92.92	179.80	-
EV/Sales Ratio	5.43	4.05	2.84	3.85	3.90	16.52
EV/EBITDA Ratio	43.16	34.82	-	-	70.59	-
EV/EBIT Ratio	43.94	35.52	-	-	87.93	-
EV/FCF Ratio	24.94	20.10	47.25	79.10	150.72	-
Debt / Equity Ratio	0.01	0.01	0.02	0.02	0.01	0.01
Debt / EBITDA Ratio	0.10	0.12	-	-	0.49	-
Debt / FCF Ratio	0.06	0.07	0.39	0.93	1.04	-
Net Debt / Equity Ratio	-0.76	-0.71	-0.53	-0.44	-0.47	-0.95
Net Debt / EBITDA Ratio	-4.84	-5.14	5.32	8.49	-15.17	1.14
Net Debt / FCF Ratio	-2.79	-2.97	-9.20	-14.74	-32.39	1.39
Asset Turnover	0.95	1.01	0.76	0.55	0.64	0.13
Inventory Turnover	1.26	1.91	2.12	1.27	1.81	4.95
Quick Ratio	3.14	3.09	2.84	3.58	4.48	4.15
Current Ratio	3.79	3.79	3.30	4.34	5.16	4.38
Return on Equity (ROE)	12.45%	11.73%	-9.85%	3.37%	63.10%	-63.55%
Return on Assets (ROA)	14.37%	15.35%	-6.64%	-14.54%	-41.30%	-53.33%
Return on Invested Capital (ROIC)	44.22%	39.05%	-13.76%	-28.79%	-105.00%	-520.64%
Return on Capital Employed (ROCE)	14.42%	13.98%	-9.68%	-5.76%	3.25%	-61.96%
Earnings Yield	1.60%	1.82%	-	1.14%	17.36%	-
FCF Yield	3.61%	4.33%	1.77%	1.07%	0.55%	-
Buyback Yield / Dilution	-11.98%	-10.58%	0.69%	-2.13%	-2.69%	-10.89%
Total Shareholder Return	-11.98%	-10.58%	0.69%	-2.13%	-2.69%	-10.89%

SEC Filings: 10-K · 10-Q